Gpax Pharmaceuticals Private Limited

Gpax Pharmaceuticals Private Limited - pharma in Navi Mumbai, Maharashtra, India. FY 2026 financials & compliance.
CIN U24233MH2014PTC258452 Incorporated 30 September 2014 ROC Mumbai HQ Navi Mumbai, Maharashtra, India
Active Private Limited Company pharma MSME · Small
Data last updated
Revenue · FY 2025
₹18.67 Cr
▲ 47% YoY
Net loss · FY 2025
₹5.68 Cr
Net margin -30.4%
EBITDA · FY 2025
-₹3.58 Cr
EBITDA margin -19.2%
Authorised capital
₹20 Cr
Registered with MCA
Paid-up capital
₹17.69 Cr
Issued & subscribed
Open charges
₹17.38 Cr
Secured borrowings
Company age
12 yrs
Est. 2014
Employees · EPFO
184
Provident fund records

About Gpax Pharmaceuticals Private Limited

Data last updated:

Gpax Pharmaceuticals Private Limited is a private limited company based in Navi Mumbai, Maharashtra, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 30 September 2014 and has been in existence for over 12 years.

The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U24233MH2014PTC258452. Its GSTIN is 26AAFCC7964F1ZG (Daman & Diu). The company holds 3 GST registrations, of which 1 is active.

The company has an authorised share capital of ₹20 Cr and a paid-up capital of ₹17.69 Cr. It was formerly known as Celogen Generics Private Limited. It is led by directors including Anuj Somchand Bhagwanji Shah and Amit Rajan.

Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Off B – 106 Techno City Pl X – 4/1 X – 4/2 Ttc Area MIDC Mahape, Navi Mumbai, Maharashtra, India – 400701.

As per the financials filed for FY 2025, the company reported a revenue of ₹18.67 Cr, a growth of 47% compared to the previous year. For the same year it recorded a net loss of ₹5.68 Cr (net margin -30.4%) and EBITDA of -₹3.58 Cr (EBITDA margin -19.2%). Revenue has grown at a compounded annual rate (CAGR) of 10% over three years and 11% over five years.

The company has about 184 employees on its provident fund (EPFO) records.

As per MCA filings, the company has open charges of ₹17.38 Cr on record. Court records list 13 cases involving the company, including 13 filed against it; 3 cases are pending. The company has 6 deals on record (2 convertible or debt financings, 2 secondary share transfers, 1 rights issue), with disclosed funding of ₹7.5 Cr; the latest was in March 2017. Its 4 peer companies in the Pharma industry (Formulations, Pharmaceuticals), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products) are compared by revenue, 2 larger and 2 smaller; the largest is Indu Drugs Private Limited with revenue of ₹18.78 Cr. The company has 1 MSME Form 1 return on record for the period ending Mar 2019, listing 97 overdue payments to 7 micro and small suppliers.

Gpax Pharmaceuticals Private Limited is registered as a small enterprise under the Udyam registration framework (Reg. No. UDYAM-DD-01-0001109). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website celogenpharma.com.

Company details

CIN U24233MH2014PTC258452
Registration Number 258452
Incorporation Date 30 September 2014
ROC Mumbai
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant
MSME Classification Small
Udyam Registration UDYAM-DD-01-0001109
Key People
Anuj Somchand Bhagwanji Shah Director Amit Rajan Director Vikash Naresh Shah Director

Recognitions & Rankings of Gpax Pharmaceuticals

MSME (Udyam registered) Ministry of MSME
Category
Small (2023-24)
Udyam number
UDYAM-DD-01-0001109

Contact details

Gpax Pharmaceuticals Private Limited's registered office is in Navi Mumbai, Maharashtra. Its website is celogenpharma.com. Its e-mail address and telephone number are in the company report.

  • Email
  • Telephone
  • Website
    celogenpharma.com
  • Registered Address
    Off B – 106 Techno City Pl X – 4/1 X – 4/2 Ttc Area MIDC Mahape, Navi Mumbai, Maharashtra, India – 400701
  • Industry
    Pharma, Drug Formulation & Development

To see the full contact details of Gpax Pharmaceuticals Private Limited, buy the company report.

Comprehensive company report
Gpax Pharmaceuticals Private Limited - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included

Financials of Gpax Pharmaceuticals Private Limited

FY 2025 filings available

Gpax Pharmaceuticals Private Limited reported revenue of ₹18.67 Cr (up 47% YoY) for FY 2025.

Revenue · FY 2025
₹18.67 Cr ▲ 47%
Net loss · FY 2025
₹5.68 Cr margin -30.4%
EBITDA · FY 2025
-₹3.58 Cr margin -19.2%

Compounded Annual Growth Rate (CAGR)

Revenue CAGR growth
1 year
▲ 47%
3 years · compounded
▲ 10%
5 years · compounded
▲ 11%
EBITDA CAGR growth
3 years · compounded
▼ 37%
5 years · compounded
▼ 1%

Revenue has grown at a compounded annual rate (CAGR) of 11% over five years, including 47% growth in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.

Financial Statement Summary

MetricsFY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21
Profit and Loss Statement
Revenue from Operations
Other Income
Total Revenue
Cost of Materials Consumed
Employee Benefit Expense
Finance Costs
Depreciation and Amortisation
Other Expenses
Total Expenses
EBITDA-₹3.58 Cr
Profit Before Tax
Tax Expense
Net Profit (PAT)-₹5.68 Cr
Balance Sheet
Share Capital
Reserves and Surplus
Net Worth (Total Equity)
Long-term Borrowings
Short-term Borrowings
Trade Payables
Total Liabilities
Fixed Assets
Investments
Inventories
Trade Receivables
Cash and Bank Balance
Total Assets

Financial Ratios

MetricsFY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21
Profitability
EBITDA Margin-19.2%
Net Profit Margin-30.4%
Return on Equity (ROE)
Return on Capital Employed (ROCE)
Return on Assets (ROA)
Liquidity and Debt
Current Ratio
Quick Ratio
Debt-to-Equity Ratio
Interest Coverage Ratio
Efficiency and Growth
Asset Turnover
Receivable Days
Payable Days
Inventory Days
Revenue Growth
Net Profit Growth

To see the full financial statements and ratios of Gpax Pharmaceuticals Private Limited, buy the company report.

Board of directors of Gpax Pharmaceuticals Private Limited

Gpax Pharmaceuticals has 8 current directors and 6 former directors. Current directors are listed first, with their designation and appointment date.

Current Directors
NameDesignationAppointment DateTenureStatus
Anuj Somchand Bhagwanji ShahDirector19 Jan 20242 Years 9 MonthsCurrent
Amit Rajan
Also directs: Celogen Lifescience & Technologies Private Limited, Prosfora Technologies Private Limited
Director02 Jan 201511 Years 9 MonthsCurrent
Vikash Naresh ShahDirector19 Jan 20242 Years 9 MonthsCurrent
Bharat Kakubhai Katariya
Also directs: Arkianav Private Limited
Director19 Jan 20242 Years 9 MonthsCurrent
Shailesh Kakulal KatariaDirector19 Jan 20242 Years 9 MonthsCurrent
Rabi Narayan Nayak
Also directs: Celogen Pharma Private Limited, Agam and Gem Laboratories Private Limited, Celogen Laboratories Private Limited and 2 more
Director30 Sep 201412 Years 1 MonthsCurrent
Showing 6 of 8 current directors. View all directors

Peer comparison

Gpax Pharmaceuticals Private Limited is compared with the 4 companies closest to it by revenue in the Pharma industry (Formulations, Pharmaceuticals), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.

CompanyRevenueNet profitMarginGrowth (1 yr)EmployeesLocation
Indu Drugs Private Limited₹18.78 Cr (FY 2025)-10.0%Hyderabad, Telangana, India
Gulkas Pharma Pvt Ltd₹18.78 Cr (FY 2025)21.0%Kalol, Gujarat, India
Gpax Pharmaceuticals Private Limitedthis company₹18.67 Cr (FY 2025)-₹5.68 Cr-30.4%47.0%184Navi Mumbai, Maharashtra, India
Medilife Impex Private Limited₹18.66 Cr (FY 2025)3.0%Hingna, Maharashtra, India
Sai Sarvaa Biotech Private Limited₹18.57 Cr (FY 2025)3.0%Villupuram, Tamil Nadu, India

To see the full peer comparison of Gpax Pharmaceuticals Private Limited, buy the company report.

Auditor

Gpax Pharmaceuticals Private Limited is audited by ANRK & ASSOCIATES LLP for the financial year 2023.

Auditor firmFinancial yearFirm registration number
ANRK & ASSOCIATES LLPFY 2023W100001

Shareholding

The shareholding of Gpax Pharmaceuticals Private Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.

Shareholder categoryFY 2023FY 2022FY 2021FY 2020FY 2019
Promoters
Domestic institutional investors (DII)
Foreign institutional investors (FII)
Public
Others

To see the full shareholding pattern of Gpax Pharmaceuticals Private Limited, buy the company report.

Charges & borrowings

Open charges
₹17.38 Cr
Satisfied charges
None
Breakdown by lending institutions
Nkgsb Co.Op. Bank Ltd.₹8.85 Cr
Others₹8.53 Cr
Latest charge details
DateCharge IDLenderAmountStatusModified or satisfied on
31 Mar 2023100696852Others₹2.55 CrOpen
27 Jul 2018100258224Others₹97.5 LakhOpen
18 Jul 2018100258219Others₹2.5 CrOpen
26 Oct 201510602131Nkgsb Co.Op. Bank Ltd.₹85 LakhOpen
01 Aug 201510585882Others₹2.5 CrOpen

To see the full charge records of Gpax Pharmaceuticals Private Limited, buy the company report.

Total charge records: 6 View all charges

Deals & funding

Gpax Pharmaceuticals Private Limited has 6 deals on record (2 convertible or debt financings, 2 secondary share transfers, 1 rights issue), with disclosed funding of ₹7.5 Cr; the latest was in March 2017.

Total deals
6
Convertible or debt financings
2
Secondary share transfers
2
Rights issue
1
Funding round
1
Disclosed funding
₹7.5 Cr

Deals on record (4 of 6)

WhenDealAmountParties
Mar 2017Secondary share transferUndisclosedBuyer: an individual
Seller: 3 individuals
Jun 2015Rights issue₹1.29 CrInvestors: 4 individuals
Apr 2015Funding round₹1.25 CrInvestors: an individual
Nov 2014Secondary share transferUndisclosedBuyer: 3 individuals
Seller: an individual

To see the full deal history of Gpax Pharmaceuticals Private Limited, buy the company report.

Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.

MSME payment delays

Gpax Pharmaceuticals Private Limited has 1 MSME Form 1 return on record for the period ending Mar 2019, listing 97 overdue payments to 7 micro and small suppliers. Companies must report dues to micro and small suppliers that stay unpaid for more than 45 days in a half-yearly MSME Form 1 return.

Suppliers with reported dues (5 of 7)

SupplierAmount dueDue sinceReported on
an individual supplier
Icm Plastics Private Limited
an individual supplier
Times Press People Private Limited
an individual supplier

To see the full MSME payment records of Gpax Pharmaceuticals Private Limited, buy the company report.

Individuals and sole proprietors among the suppliers are not named.

Employees & EPFO

Gpax Pharmaceuticals Private Limited has a workforce of 184 employees on its EPFO records as of Apr 06, 2024, across 1 active EPFO establishment.

Employee count
184
Active EPFO establishments
1
Employee growth
37.31%

GST

Gpax Pharmaceuticals has 3 GST registrations: 1 active and 2 cancelled or inactive.

Total GSTINs
3
Active
1
Cancelled / inactive
2
GSTINStateStatusRegistered on
26AAFCC7964F1ZGDaman & DiuActive01 Aug 2020

To see the full GST registrations and return filing status of Gpax Pharmaceuticals Private Limited, buy the company report.

Recent activity

Gpax Pharmaceuticals Private Limited has 14 board changes on record since 2014: 8 appointments and 6 cessations. The latest: Anuj Somchand Bhagwanji Shah was appointed as Director on 19 Jan 2024.

AGM
Gpax Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Gpax Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Mumbai.
Appointed
Anuj Somchand Bhagwanji Shah was appointed as Director.
Appointed
Bharat Kakubhai Katariya was appointed as Director.
Appointed
Shailesh Kakulal Kataria was appointed as Director.
Appointed
Vikash Naresh Shah was appointed as Director.
Charges
A charge with Others amounted to Rs. 2.55 Cr with Charge ID 100696852 was registered on 31 Mar 2023.
Ceased
Vikash Naresh Shah ceased to be Director.
Ceased
Aakash Vithalbhai Patel ceased to be Director.
Charges
A charge with Others of Rs. 0.98 Cr registered on 27 Jul 2018 with Charge ID 100258224 was modified on 10 Sep 2018.
Charges
A charge with Others amounted to Rs. 0.98 Cr with Charge ID 100258224 was registered on 27 Jul 2018.
Charges
A charge with Others of Rs. 2.50 Cr registered on 18 Jul 2018 with Charge ID 100258219 was modified on 27 Jul 2018.

14 earlier events are in the company report.

Frequently asked questions

Gpax Pharmaceuticals is an active private limited company based in Navi Mumbai, Maharashtra, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 30 September 2014 (12+ years old) and is registered under CIN U24233MH2014PTC258452.

Gpax Pharmaceuticals has 8 current directors:

The latest financial statements of Gpax Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.

The GSTIN of Gpax Pharmaceuticals is 26AAFCC7964F1ZG, registered in Daman & Diu. The company has 3 GST registrations in all, of which 1 is active and 2 are cancelled or inactive.

The CIN (Corporate Identification Number) of Gpax Pharmaceuticals is U24233MH2014PTC258452. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.

Gpax Pharmaceuticals has 13 court cases on record: 13 filed against it. 3 are pending. Most are in the district courts.

Gpax Pharmaceuticals was incorporated on 30 September 2014, making it 12+ years old. It is registered with the Registrar of Companies, Mumbai.

Gpax Pharmaceuticals has 6 deals on record (2 convertible or debt financings, 2 secondary share transfers, 1 rights issue), with disclosed funding of ₹7.5 Cr; the latest was in March 2017.

The peers of Gpax Pharmaceuticals by revenue are Indu Drugs Private Limited, Gulkas Pharma Pvt Ltd, Medilife Impex Private Limited, Sai Sarvaa Biotech Private Limited, all in the Pharma industry (Formulations, Pharmaceuticals), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).

Anuj Somchand Bhagwanji Shah was appointed as Director on 19 Jan 2024. Bharat Kakubhai Katariya was appointed as Director on 19 Jan 2024. Shailesh Kakulal Kataria was appointed as Director on 19 Jan 2024. Gpax Pharmaceuticals has 14 board changes on record in total.

Yes, Gpax Pharmaceuticals is registered as a small enterprise under Udyam registration (number: UDYAM-DD-01-0001109).

Gpax Pharmaceuticals has 1 MSME Form 1 return on record for the period ending Mar 2019, listing 97 overdue payments to 7 micro and small suppliers. The latest return was filed on 14 Jun 2019.